What the landmark opioid ruling means for drug companies

An Oklahoma judge ordered pharmaceutical giant Johnson & Johnson to pay over $500 million for its role in the state’s opioid crisis. Today, Crain’s health care reporter Stephanie Goldberg talks about why the case is significant.
Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.